TFA
ARCT icon

Toth Financial Advisory’s Arcturus Therapeutics ARCT Stock Holding History

Toth Financial Advisory’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30
Closed -$1K – 695
2022
Q1 		$1K Hold
30
– – ﹤0.01% 656
2021
Q4 		$1K Hold
30
– – ﹤0.01% 680
2021
Q3 		$1K Hold
30
– – ﹤0.01% 694
2021
Q2 		$1K Hold
30
– – ﹤0.01% 635
2021
Q1 		$1K Buy
+30
New +$1.79K ﹤0.01% 630

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toth Financial Advisory's ARCT Position: Q2 2022 in Review

Toth Financial Advisory sold out of Arcturus Therapeutics (ARCT) in Q2 2022, closing a stake of 30 shares — an estimated $1K sold.

Toth Financial Advisory first reported a position in ARCT in Q1 2021 and held it in 5 quarters. The position peaked at $1K in Q1 2022. 128 funds tracked by Wall St. Rank hold ARCT as of Q2 2022.

  • Toth Financial Advisory reported no remaining Arcturus Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Toth Financial Advisory sold 30 Arcturus Therapeutics shares in Q2 2022, an estimated $1K.
  • Toth Financial Advisory first reported a position in Arcturus Therapeutics in Q1 2021 and held it in 5 quarters.
  • Toth Financial Advisory's Arcturus Therapeutics position peaked at $1K in Q1 2022.
  • 128 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2022.

Based on Toth Financial Advisory's 13F filing for Q2 2022, filed 25 Jul 2022.